At a glance
- Originator Aventis
- Class Antiasthmatics; Benzopyrans; Muscle relaxants
- Mechanism of Action Leukotriene receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 20 Feb 1995 Discontinued-Preclinical for Asthma in USA (Unknown route)